Literature DB >> 20715931

Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors.

Annette Audigé1, Patrick Taffé, Martin Rickenbach, Manuel Battegay, Pietro Vernazza, David Nadal, Roberto F Speck.   

Abstract

CD4 expression in HIV replication is paradoxical: HIV entry requires high cell-surface CD4 densities, but replication requires CD4 down-modulation. However, is CD4 density in HIV+ patients affected over time? Do changes in CD4 density correlate with disease progression? Here, we examined the role of CD4 density for HIV disease progression by longitudinally quantifying CD4 densities on CD4+ T cells and monocytes of ART-naive HIV+ patients with different disease progression rates. This was a retrospective study. We defined three groups of HIV+ patients by their rate of CD4+ T cell loss, calculated by the time between infection and reaching a CD4 level of 200 cells/microl: fast (<7.5 years), intermediate (7.5-12 years), and slow progressors (>12 years). Mathematical modeling permitted us to determine the maximum CD4+ T cell count after HIV seroconversion (defined as "postseroconversion CD4 count") and longitudinal profiles of CD4 count and density. CD4 densities were quantified on CD4+ T cells and monocytes from these patients and from healthy individuals by flow cytometry. Fast progressors had significantly lower postseroconversion CD4 counts than other progressors. CD4 density on T cells was lower in HIV+ patients than in healthy individuals and decreased more rapidly in fast than in slow progressors. Antiretroviral therapy (ART) did not normalize CD4 density. Thus, postseroconversion CD4 counts define individual HIV disease progression rates that may help to identify patients who might benefit most from early ART. Early discrimination of slow and fast progressors suggests that critical events during primary infection define long-term outcome. A more rapid CD4 density decrease in fast progressors might contribute to progressive functional impairments of the immune response in advanced HIV infection. The lack of an effect of ART on CD4 density implies a persistent dysfunctional immune response by uncontrolled HIV infection.

Entities:  

Mesh:

Year:  2010        PMID: 20715931     DOI: 10.1089/aid.2009.0263

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control.

Authors:  T Whittall; B Peters; D Rahman; C I Kingsley; R Vaughan; T Lehner
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061.

Authors:  Iris Chen; Wei Huang; Matthew B Connor; Arne Frantzell; Vanessa Cummings; Geetha G Beauchamp; Sam Griffith; Sheldon D Fields; Hyman M Scott; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Hong-Van Tieu; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  HIV Clin Trials       Date:  2016-06-14

3.  Previously Unidentified Single Nucleotide Polymorphisms in HIV/AIDS Cases Associate with Clinical Parameters and Disease Progression.

Authors:  Vladimir V Anokhin; Liliia B Bakhteeva; Gulshat R Khasanova; Svetlana F Khaiboullina; Ekaterina V Martynova; Richard L Tillett; Karen A Schlauch; Vincent C Lombardi; Albert A Rizvanov
Journal:  Biomed Res Int       Date:  2016-12-05       Impact factor: 3.411

4.  Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Authors:  Joakim Esbjörnsson; Patrik Medstrand; Angelica A Palm; Philippe Lemey; Marianne Jansson; Fredrik Månsson; Anders Kvist; Zsófia Szojka; Antonio Biague; Zacarias José da Silva; Sarah L Rowland-Jones; Hans Norrgren
Journal:  mBio       Date:  2019-01-08       Impact factor: 7.867

5.  Evaluation of rapid progressors in HIV infection as an extreme phenotype.

Authors:  Ashley D Olson; Marguerite Guiguet; Robert Zangerle; John Gill; Santiago Perez-Hoyos; Sara Lodi; Jade Ghosn; Maria Dorrucci; Anne Johnson; Mette Sannes; Santiago Moreno; Kholoud Porter
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 6.  The natural history of HIV infection.

Authors:  Caroline A Sabin; Jens D Lundgren
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.